292 related articles for article (PubMed ID: 23665153)
21. Muscle wasting: the gut microbiota as a new therapeutic target?
Bindels LB; Delzenne NM
Int J Biochem Cell Biol; 2013 Oct; 45(10):2186-90. PubMed ID: 23831839
[TBL] [Abstract][Full Text] [Related]
22. [Congestive heart failure: from cardiac muscle to skeletal muscle].
Ferrari R; Bernocchi P; Boraso A; Visioli O
Cardiologia; 1993 Dec; 38(12 Suppl 1):45-50. PubMed ID: 8020046
[TBL] [Abstract][Full Text] [Related]
23. Research hypotheses on muscle wasting, aging, loss of function and disability.
Pahor M; Kritchevsky S
J Nutr Health Aging; 1998; 2(2):97-100. PubMed ID: 10993575
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in the biology and therapy of muscle wasting.
Glass D; Roubenoff R
Ann N Y Acad Sci; 2010 Nov; 1211():25-36. PubMed ID: 21062293
[TBL] [Abstract][Full Text] [Related]
25. Muscle wasting in cancer and ageing: cachexia versus sarcopenia.
Argilés JM; Busquets S; Felipe A; López-Soriano FJ
Adv Gerontol; 2006; 18():39-54. PubMed ID: 16676797
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin II as candidate of cardiac cachexia.
Delafontaine P; Akao M
Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):220-4. PubMed ID: 16607120
[TBL] [Abstract][Full Text] [Related]
27. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
28. Myostatin: Regulator of muscle wasting in heart failure and treatment target for cardiac cachexia.
Springer J; Adams V; Anker SD
Circulation; 2010 Jan; 121(3):354-6. PubMed ID: 20065169
[No Abstract] [Full Text] [Related]
29. Control of muscle size during disuse, disease, and aging.
Degens H; Alway SE
Int J Sports Med; 2006 Feb; 27(2):94-9. PubMed ID: 16475053
[TBL] [Abstract][Full Text] [Related]
30. Mechanism and novel therapeutic approaches to wasting in chronic disease.
Ebner N; Springer J; Kalantar-Zadeh K; Lainscak M; Doehner W; Anker SD; von Haehling S
Maturitas; 2013 Jul; 75(3):199-206. PubMed ID: 23664695
[TBL] [Abstract][Full Text] [Related]
31. Detection of muscle wasting in patients with chronic heart failure using C-terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF).
Steinbeck L; Ebner N; Valentova M; Bekfani T; Elsner S; Dahinden P; Hettwer S; Scherbakov N; Schefold JC; Sandek A; Springer J; Doehner W; Anker SD; von Haehling S
Eur J Heart Fail; 2015 Dec; 17(12):1283-93. PubMed ID: 26449626
[TBL] [Abstract][Full Text] [Related]
32. Mechanisms of skeletal muscle atrophy.
Ventadour S; Attaix D
Curr Opin Rheumatol; 2006 Nov; 18(6):631-5. PubMed ID: 17053511
[TBL] [Abstract][Full Text] [Related]
33. [Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].
Argilés JM; Busquets S; López-Soriano FJ; Figueras M
Nutr Hosp; 2006 May; 21 Suppl 3():38-45. PubMed ID: 16768029
[TBL] [Abstract][Full Text] [Related]
34. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
Dalton JT; Taylor RP; Mohler ML; Steiner MS
Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
[TBL] [Abstract][Full Text] [Related]
35. Stroke induced Sarcopenia: muscle wasting and disability after stroke.
Scherbakov N; von Haehling S; Anker SD; Dirnagl U; Doehner W
Int J Cardiol; 2013 Dec; 170(2):89-94. PubMed ID: 24231058
[TBL] [Abstract][Full Text] [Related]
36. Malnutrition, muscle wasting and cachexia in chronic heart failure: the nutritional approach.
Pasini E; Aquilani R; Gheorghiade M; Dioguardi FS
Ital Heart J; 2003 Apr; 4(4):232-5. PubMed ID: 12784775
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
Argilés JM; López-Soriano FJ; Busquets S
Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
[TBL] [Abstract][Full Text] [Related]
38. Glucocorticoid-induced skeletal muscle atrophy.
Schakman O; Kalista S; Barbé C; Loumaye A; Thissen JP
Int J Biochem Cell Biol; 2013 Oct; 45(10):2163-72. PubMed ID: 23806868
[TBL] [Abstract][Full Text] [Related]
39. Muscle atrophy is not always sarcopenia.
Hepple RT
J Appl Physiol (1985); 2012 Aug; 113(4):677-9. PubMed ID: 22518833
[No Abstract] [Full Text] [Related]
40. Sarcopenia, cachexia and congestive heart failure in the elderly.
Zamboni M; Rossi AP; Corzato F; Bambace C; Mazzali G; Fantin F
Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):58-67. PubMed ID: 23369138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
